Jaume Bordas-Martinez
Jaume Bordas-Martinez is an expert in Pulmonology at Hospital General de Granollers (Spain). Jaume Bordas-Martinez has authored 25 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 4 of them ongoing. SLR score: 158 (community average: 125). How the SLR is computed.
LeadR Profile
Pulmonology
Subspecialties: Public Health - Oncology - Internal Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Organizations
Career arc: 2015 - 2026
Number : 25
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| A prospective cohort study for characterization and predictive factors of long-term POST-COVID interstitial changes. PMID 42021247 — cohort studies, respiratory physiological phenomena | Respir Res | 2026 | 0 |
| Viability of a new home program of forced spirometry with bronchodilator response measurement in the assessment of patients with asthma. PMID 40464088 — research design, bronchodilator agents, spirometry, asthma, vital capacity | Multidiscip Respir Med | 2025 | 0 |
| Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial. PMID 40154560 — quality of life, lung, safety, fibrosis, respiratory tract diseases, respiration, pharmaceutical preparations, covid-19, pulmonary fibrosis, vital capacity | Eur Respir J | 2025 | 9 |
| Mediastinal staging lymph node probability map in non-small cell lung cancer. PMID 40128853 — cells, lung, lymph nodes, probability, neoplasms, carcinoma, non-small-cell lung, respiratory physiological phenomena, algorithms, lung neoplasms, lymph, small cell lung carcinoma | Respir Res | 2025 | 1 |
| Treating sleep-disordered breathing of idiopathic pulmonary fibrosis patients with CPAP and nocturnal oxygen treatment. A pilot study : Sleep-disordered breathing treatment in IPF. PMID 38890648 — pilot projects, idiopathic pulmonary fibrosis, quality of life, pilots, lung, blood, fibrosis, respiration, sleep, polysomnography, respiratory physiological phenomena, pulmonary fibrosis, sleep apnea syndromes, therapeutics | Respir Res | 2024 | 7 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Finger Versus Earlobe Pulse Oximetry During the 6 Minute Walk Test in Interstitial Lung Disease NCT07723872 — exercise, research design, sclerosis, idiopathic pulmonary fibrosis, lung, reading, fibrosis, heart rate, heart, connective tissue, oximetry, recycling, connective tissue diseases, pulmonary fibrosis, therapeutics, lung diseases, tissues, walk test, scleroderma, systemic, pulse, lung diseases, interstitial, oxygen saturation | N/A | Recruiting | 2026 |
| Optimizing the Follow Up Journey in Interstitial Lung Disease The OPTIMIZE ILD 2 Trial NCT07486206 — idiopathic pulmonary fibrosis, quality of life, rheumatology, lung, laboratories, waiting lists, fibrosis, internal medicine, carbon footprint, connective tissue, caregivers, nursing, workflow, pharmacy, connective tissue diseases, aftercare, nursing assessment, pulmonary fibrosis, health services research, research, therapeutics, lung diseases, tissues, immunosuppression therapy, walk test, health services, lung diseases, interstitial | N/A | Recruiting | 2026 |
| Optimizing the Diagnostic Journey in Interstitial Lung Disease The OPTIMIZE ILD 1 Trial NCT07482917 — idiopathic pulmonary fibrosis, quality of life, rheumatology, lung, diagnostic techniques and procedures, laboratories, waiting lists, clinical decision-making, fibrosis, tomography, internal medicine, carbon footprint, bronchoalveolar lavage, connective tissue, caregivers, workflow, decision making, bronchoscopy, connective tissue diseases, spirometry, pulmonary fibrosis, health services research, diagnosis, research, time-to-treatment, therapeutics, lung diseases, tissues, walk test, health services, lung diseases, interstitial | N/A | Recruiting | 2026 |
| Integrating Molecular Genomic Morphology and Environmental Features to Improve Precision Diagnosis and Treatment in Interstitial Lung Diseases (PRECISION ILD) NCT05998512 — registries, environmental exposure, lung, fibrosis, biomarkers, diagnosis, research, therapeutics, lung diseases, prognosis, lung diseases, interstitial | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map